• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

University of Miami Health to Launch New Precision Medicine Initiative for Personalized Cancer Care

by Fred Pennic 04/05/2017 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

University of Miami Health to Launch New Precision Medicine Initiative for Personalized Cancer Care

Sylvester Comprehensive Cancer Center, part of UHealth – the University of Miami Health System, announced today is it partnering with Syapse to launch a scalable precision medicine initiative that will benefit thousands of cancer patients in South Florida and improve survival rates. The partnership with Syapse will enable doctors at UMiami’s Sylvester Comprehensive Cancer Center to deliver personalized care that matches patients with targeted, cutting-edge cancer therapies, resulting in better health outcomes and lower costs.

With this partnership, Sylvester joins a growing number of leading health systems that are turning to precision medicine and choosing Syapse to do so, including Intermountain Healthcare, Providence St. Joseph’s Health, Stanford Healthcare, Henry Ford Health System, Catholic Health Initiatives, Dignity Health, and many more. Syapse powers the OPeN Network, the largest precision medicine data-consortium in the world, which Joe Biden announced last year as part of the Cancer Moonshot Initiative. The new partnership with Syapse allows Sylvester doctors to access that consortium.

The platform centralizes, organizes, and presents structured clinical and genomic data to providers at the point of care. The robust data infrastructure and provider-facing interface support complex clinical decisions, facilitate new provider workflows, and enable data-driven quality improvement efforts. Syapse enables data sharing across health systems, supporting the nation’s largest precision oncology data-sharing network. Health systems can access real-world treatment and outcomes data on clinically and molecularly similar patients, rapidly advancing the quality of care using real-world evidence.

“We are excited about this partnership with Syapse because it will help us ensure that our cancer patients receive the best precision care,” said Jonathan C. Trent, M.D., Ph.D., associate director of clinical research at Sylvester and professor of medicine at the University of Miami Miller School of Medicine. “Matching a cancer patient with a certain treatment based on the cancer’s molecular profile is among the most promising treatment options in this age of personalized medicine.”

“No other cancer center or hospital in South Florida offers the breadth of personalized treatment options as Sylvester,” said Trent. “At Sylvester, we understand that each patient is unique, that each cancer is unique, and, consequently, each cancer treatment has to be unique. This partnership with Syapse helps us achieve that goal.” 

 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Precision Medicine Initiative, Precision Medicine Oncology

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |